WHO ICTRP trial
To evaluate efficacy and safety of NRAHG001 on ability of heart and lungs to…
CTRI/2024/10/075637 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/10/075637 |
|---|---|
| Public title | To evaluate efficacy and safety of NRAHG001 on ability of heart and lungs to deliver oxygen in healthy subjects. |
| Scientific title | A randomised, prospective, double-blind, placebo-controlled, clinical study to evaluate efficacy and safety of NRAHG001 on cardiorespiratory endurance and fatigue in healthy subjects. - Nil |
| Primary sponsor | Natural Remedies Private Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Interventions | Intervention1: NRAHG001 capsule: 30 mg capsule once daily in the morning either before or after food for 56 days. Control Intervention1: Placebo: 30 mg capsule once daily in the morning either before or after food for 56 days. |
| Registration date | Oct 22, 2024 |
| Target size | 66 |
| Secondary IDs | ECTS/24/006, Version 00, Date: 30 SEP 2024 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: